Monday 11 November 21 sessions
Tuesday 12 November 25 sessions
Wednesday 13 November 30 sessions
Robert Pope
Robert Pope
OC2.3
Mon 11 15:05 Oral Communications 2 - Neuroendocrinology, Pituitary and Neoplasia
ErbB receptor signalling in MCF7 breast cancer cells: an information theoretic approach
Joseph Verbalis
Joseph Verbalis
IN1.2
Mon 11 17:05 Innovation Session 1: Advances in understanding skeletal disease
Hyponatremia and osteoporosis
Tom Scanlan
Tom Scanlan
S4.3
Wed 13 10:50 Symposium 4: Thyroid hormone a key regulator in inflammation?
TED novel agents how they work and how to use them CIRTED MINGO papers
Dr Abd Tahrani
Abd Tahrani
HDI1.6
Mon 11 11:05 How do I…1
How do I choose between weight loss interventions?
Dr Abd Tahrani
Abd Tahrani
S5.3
Wed 13 10:50 Symposium 5: Stress – The rhythm of life
The interplay between sleep and the endocrine system
Dr Barbara McGowan Shazia Hussain
Shazia Hussain
OP2.1
Mon 11 13:20 Oral Posters 2 - Thyroid
Day case radioiodine for remnant ablation in differentiated thyroid cancer patients is safe and helps reduce bed pressures in a busy tertiary centre hospital
Sophia Sakka
Sophia Sakka
HDI1.1
Mon 11 11:05 How do I…1
Management of osteoporosis in children and adolescents
Dr. Caroline Gorvin
Caroline Gorvin
WIN1
Mon 11 10:20 What Is New
What is New in Basic Endocrinology Research
Dr John Newell-Price
John Newell-Price
WIN2
Mon 11 10:20 What Is New
What is New in Clinical Endocrinology Research
Dr John Newell-Price
John Newell-Price
HDI2.1
Tue 12 16:45 How do I…2
How do I diagnose cyclical Cushing's
Professor Kristien Boelaert
Kristien Boelaert
HDI1.2
Mon 11 11:05 How do I…1
How do I manage an incidental finding of a thyroid nodule
Sarah Ali
Sarah Ali
HDI1.3
Mon 11 11:05 How do I…1
How do I decide which patients with gynaecomastia need more detailed evaluation?
Aled Rees
Aled Rees
HDI1.4
Mon 11 11:05 How do I…1
How do I manage hair loss and hair growth in PCOS?
Umasuthan Srirangalingam
Umasuthan Srirangalingam
HDI1.5
Mon 11 11:05 How do I…1
How do I induce spermatogenesis?
Steve Ball
Steve Ball
CMW1.1
Mon 11 11:05 Clinical Management Workshop 1: Salt & Water
Management of hyponatraemia
Mark Hannon
Mark Hannon
CMW1.2
Mon 11 11:05 Clinical Management Workshop 1: Salt & Water
Diabetes Insipidus - management challenges and pitfalls
Professor Mirjam Christ-Crain
Mirjam Christ-Crain
CMW1.3
Mon 11 11:05 Clinical Management Workshop 1: Salt & Water
Co-peptin- a new player in the diagnosis of salt and water balance
Francesco Argenton
Francesco Argenton
BPW1.1
Mon 11 11:05 Basic Physiology Workshop: Modelling endocrinology in vitro, in vivo & in silico
In vivo models of endocrinology: new zebrafish models
Hugo Vankelecom
Hugo Vankelecom
BPW1.2
Mon 11 11:05 Basic Physiology Workshop: Modelling endocrinology in vitro, in vivo & in silico
In vitro models of endocrinology: organoids from pituitary and endometrium
Margaritis Voliotis
Margaritis Voliotis
BPW1.3
Mon 11 11:05 Basic Physiology Workshop: Modelling endocrinology in vitro, in vivo & in silico
In silico models of endocrinology: mathematical modelling of endocrine systems
Timothy Cole
Timothy Cole
OP1.1
Mon 11 12:45 Oral Posters 1 - Adrenal and Cardiovascular
Betamethasone/GR ChIP-Seq analysis defines a discrete set of canonical GR homodimer binding sites in primary fetal rat lung mesenchymal fibroblasts
Russell Senanayake
Russell Senanayake
OP1.3
Mon 11 12:45 Oral Posters 1 - Adrenal and Cardiovascular
Combining 11C-Metomidate PET/CT and 18F-FDG PET/CT – a new approach to phenotyping indeterminate adrenal lesions
Fiona Leslie
Fiona Leslie
OP1.4
Mon 11 12:45 Oral Posters 1 - Adrenal and Cardiovascular
Global phosphoproteomics links rapidly induced cytoplasmic signals to transcriptional control
Georgina Sneddon
Georgina Sneddon
OP2.2
Mon 11 13:20 Oral Posters 2 - Thyroid
The SH2B3 tryptophan 262 variant is associated with Graves’ disease and Addison’s disease
Anh Tran
Anh Tran
OP2.3
Mon 11 13:20 Oral Posters 2 - Thyroid
Sustained improvements in monitoring and biochemical control of hypothyroidism in primary care with the use of an electronic protocol at two year follow up
Mohammed Alshahrani
Mohammed Alshahrani
OP2.4
Mon 11 13:20 Oral Posters 2 - Thyroid
The proto-oncogene PBF mediates Src modulation of radioiodine uptake
Brian Walker
Brian Walker
PL1
Mon 11 14:00 Plenary 1:Clinical Endocrinology Trust Lecture
Controlling cortisol in cardiometabolic disease
Markus Ralser
Markus Ralser
PL2
Mon 11 14:30 Plenary 2: Society for Endocrinology Starling Medal Lecture
From its origins to the modern metabolic network
Lina Schiffer
Lina Schiffer
OC1.1
Mon 11 15:05 Oral Communications 1 - Metabolism and Obesity
Intracrine activation of 11-oxygenated androgens by AKR1C3 modulates lipid metabolism in human female adipose tissue
Leanne Hodson
Leanne Hodson
OC1.2
Mon 11 15:05 Oral Communications 1 - Metabolism and Obesity
Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism
Dr Mark Turner
Mark Turner
OC1.3
Mon 11 15:05 Oral Communications 1 - Metabolism and Obesity
Metabolic and functional effects of fatty acid overload on in vitro tissue engineered skeletal muscle.
Nikolaos Nikolaou
Nikolaos Nikolaou
OC1.4
Mon 11 15:05 Oral Communications 1 - Metabolism and Obesity
5β-reductase (AKR1D1) is downregulated in patients with non-alcoholic fatty liver disease and protects against hepatocellular carcinoma cell proliferation in vitro.
Federica Cuozzo
Federica Cuozzo
OC1.5
Mon 11 15:05 Oral Communications 1 - Metabolism and Obesity
Prolyl-hydroxylase 3 maintains β-cell glucose-sensing under metabolic stress
Elina Akalestou
Elina Akalestou
OC1.6
Mon 11 15:05 Oral Communications 1 - Metabolism and Obesity
Metabolic surgery reduces kidney SGLT2 expression in mice
Georgina Russell
Georgina Russell
OC2.1
Mon 11 15:05 Oral Communications 2 - Neuroendocrinology, Pituitary and Neoplasia
Differential effects of subcutaneous pulsatile versus oral hydrocortisone replacement therapy on fMRI resting state and task based emotional processing in Patients with Primary Adrenal insufficiency
Anisha Mistry
Anisha Mistry
OC2.2
Mon 11 15:05 Oral Communications 2 - Neuroendocrinology, Pituitary and Neoplasia
Investigating the role of AIP in pituitary tumourigenesis
Aldara Alonso
Aldara Alonso
OC2.4
Mon 11 15:05 Oral Communications 2 - Neuroendocrinology, Pituitary and Neoplasia
Investigating the role of vagal Y2R in PYY3-36-mediated appetite suppression
Angelica Gualtieri
Angelica Gualtieri
OC2.5
Mon 11 15:05 Oral Communications 2 - Neuroendocrinology, Pituitary and Neoplasia
Efnb2 controls pituitary gland development by regulating proliferation of the pituitary stem/progenitor cells and EMT within the pituitary stem cell niche.
Hussam Rostom
Hussam Rostom
OC2.6
Mon 11 15:05 Oral Communications 2 - Neuroendocrinology, Pituitary and Neoplasia
Post-operative copeptin analysis as a predictor of diabetes insipidus after pituitary surgery
Kreepa Kooblall
Kreepa Kooblall
OC3.1
Mon 11 15:05 Oral Communications 3 - Bone and Calcium
A mouse model generated by CRISPR-Cas9 with a frameshift mutation in the nuclear factor 1/X (NFIX) gene has phenotypic features reported in Marshall-Smith Syndrome (MSS) patients
Zhuo Chong
Zhuo Chong
OC3.2
Mon 11 15:05 Oral Communications 3 - Bone and Calcium
Hypophosphatasia in adulthood - are patients really “unaffected”
Lina Sorour
Lina Sorour
OC3.3
Mon 11 15:05 Oral Communications 3 - Bone and Calcium
Generation of a long acting parathyroid hormone hybrid analogue through fusion to a binding protein
Ultan Healy
Ultan Healy
OC3.5
Mon 11 15:05 Oral Communications 3 - Bone and Calcium
Mutational analysis of a patient with familial hypocalciuric hypercalcaemia identifies a novel p.Ser182Cys mutation, which is predicted to disrupt the calcium sensing receptor (CaSR) extracellular domain
Michelle Goldsworthy
Michelle Goldsworthy
OC3.6
Mon 11 15:05 Oral Communications 3 - Bone and Calcium
The role of biased calcium-sensing receptor signalling in urinary calcium excretion and kidney stone disease
M. Babu
M. Babu
IN2.2
Mon 11 17:05 Innovation Session 2: Big data in space and time
Data Science Approaches to GPCRs and Nuclear Receptors
Professor Waljit Dhillo
Waljit Dhillo
IN3.1
Mon 11 17:05 Innovation Session 3: NIHR Pathways to clinical impact
From basic science to life changing therapies
Professor John Wilding
John Wilding
IN3.2
Mon 11 17:05 Innovation Session 3: NIHR Pathways to clinical impact
Health Care Professionals, Industry and the NHS: delivering innovation
Professor John Wilding
John Wilding
D1.1
Mon 11 18:40 Debate: Nature vs Nurture
AGAINST - This house believes nature not nurture determines our bodyweight
Professor John Wilding
John Wilding
S1.3
Tue 12 11:05 Symposium 1: Gut hormones physiology pathology and pharamcology
Therapeutic landscape
Professor Márta Korbonits
Márta Korbonits
IN3.3
Mon 11 17:05 Innovation Session 3: NIHR Pathways to clinical impact
Championing Rare Disease Research
Constantine Stratakis
Constantine Stratakis
PL3
Mon 11 18:10 Plenary 3: Society for Endocrinology Dale Medal Lecture
From Carney complex to gigantism and Cushing disease: an insight in the genetics of pituitary tumors
Professor Sadaf Farooqi
Sadaf Farooqi
D1.2
Mon 11 18:40 Debate: Nature vs Nurture
FOR - This house believes nature not nurture determines our bodyweight
Michael Whyte
Michael Whyte
PL4
Tue 12 08:30 Plenary 4: Society for Endocrinology Transatlantic Medal Lecture
How is alkaline phosphatase essential for bone? The Transatlantic stories
Roger Cone
Roger Cone
PL5
Tue 12 09:00 Plenary 5: Society for Endocrinology International Medal Lecture
The Melanocortin Microcircuitry and its Role in Energy Homeostasis
Dr Alessandro Prete
Alessandro Prete
EC1.3
Tue 12 09:35 Early Careers and Plenary Orals
Urine steroid metabolome analysis allows for metabolic risk stratification in 1309 prospectively recruited patients with benign adrenal tumours and different degrees of cortisol excess
Professor Fadil Hannan
Fadil Hannan
EC1.4
Tue 12 09:35 Early Careers and Plenary Orals
CET Best Abstract Basic
Fiona Gribble
Fiona Gribble
S1.1
Tue 12 11:05 Symposium 1: Gut hormones physiology pathology and pharamcology
Physiology and pharmacology of gut hormones
Tricia Tan
Tricia Tan
S1.2
Tue 12 11:05 Symposium 1: Gut hormones physiology pathology and pharamcology
Combination of gut hormone therapy
Professor Colin Duncan
Colin Duncan
S2.2
Tue 12 11:05 Symposium 2: New insights into PCOS
PCOS, obesity and energy balance
Bijay Vaidya
Bijay Vaidya
NS1.1
Tue 12 11:05 Nurses' session 1: NICE & T3
T3 replacement – What does the evidence suggest?
Dr. Antonia Brooke
Antonia Brooke
NS1.2
Tue 12 11:05 Nurses' session 1: NICE & T3
The health care professional & patient consultation - Informed decision making
Dr. Antonia Brooke
Antonia Brooke
ROE1.3
Wed 13 15:15 Endocrinology in the UK: Workforce, Standards, and Quality Improvement
SfE Interdepartmental peer review
Jean Munday
Jean Munday
NS1.3
Tue 12 11:05 Nurses' session 1: NICE & T3
A Beginners Guide: setting up a Nurse-Led Thyroid Clinic
Dr Carla Moran
Carla Moran
MTE1
Tue 12 12:40 Meet The Expert 1
Thyroid disease after immune reconstitution
John Achermann
John Achermann
MTE3
Tue 12 12:40 Meet The Expert 3
Update on DSD genetics
Alice Mitchell
Alice Mitchell
OP3.1
Tue 12 13:30 Oral Posters 3 - Metabolism and Obesity
Intermittent cold exposure ameliorates fatty liver disease
Anastasia Arvaniti
Anastasia Arvaniti
OP3.2
Tue 12 13:30 Oral Posters 3 - Metabolism and Obesity
Intestinal injury and evidence of increased gut permeability in female AKR1D1 knockout mice
Haya Alessimii
Haya Alessimii
OP3.3
Tue 12 13:30 Oral Posters 3 - Metabolism and Obesity
The Impact of Subcutaneous Infusions of three Anorexigenic Gut Hormones Glucagon-like Peptide-1, Oxyntomodulin and Peptide YY (GOP) on the Psychological Health of Obese Diabetic Patients.
Kanapath Oungpasuk
Kanapath Oungpasuk
OP4.1
Tue 12 14:05 Oral Posters 4 - Bone and Calcium
Oral calcium loading test can predict the progression of hypercalcaemic primary hyperparathyroidism in patients with normocalcaemic hyperparathyroidism
Adam Truelove
Adam Truelove
OP4.2
Tue 12 14:05 Oral Posters 4 - Bone and Calcium
Identification of novel pathogenic variants and phenotypic features in patients with pseudohypoparathyroidism and acrodysostosis, subtypes of the newly defined inactivating PTH/PTHrP signalling disorders (iPPSD) classification system
Harshal Deshmukh
Harshal Deshmukh
OP4.3
Tue 12 14:05 Oral Posters 4 - Bone and Calcium
Mendelian randomization and machine learning to assess the causal association of Type 2 Diabetes with osteoporosis and fragility fractures
Catriona Hilton
Catriona Hilton
OP4.4
Tue 12 14:05 Oral Posters 4 - Bone and Calcium
The associations between body fat distribution and bone mineral density in the Oxford Biobank: a cross sectional study
Martin Read
Martin Read
OC4.1
Tue 12 14:45 Oral Communications 4 - Thyroid
A high-throughput yellow fluorescent protein (YFP) cell-based screen identifies autophagy modulators to increase the effectiveness of radioiodine therapy
Mohammad Jeeyavudeen
Mohammad Jeeyavudeen
OC4.2
Tue 12 14:45 Oral Communications 4 - Thyroid
Reduced Length of Hospital Stay with the use of recombinant TSH compared to Thyroid Hormone Withdrawal –A two centre retrospective study
Alina Sovetkina
Alina Sovetkina
OC4.4
Tue 12 14:45 Oral Communications 4 - Thyroid
Development of auto-immune thyroid dysfunction in multiple sclerosis patients receiving Alemtuzumab is associated with improved response to treatment
Rima Dhillon-Smith
Rima Dhillon-Smith
OC4.5
Tue 12 14:45 Oral Communications 4 - Thyroid
The prevalence of thyroid dysfunction and autoimmunity in women with history of miscarriage or subfertility across the United Kingdom
Hannah Nieto
Hannah Nieto
OC4.6
Tue 12 14:45 Oral Communications 4 - Thyroid
Driver events in thyroid cancer recurrence
Luke Boyle
Luke Boyle
OC5.2
Tue 12 14:45 Oral Communications 5 - Adrenal and Cardiovascular
Subclinical alpha-1 antitrypsin deficiency is associated with increased free cortisol fraction in plasma
Sean Bankier
Sean Bankier
OC5.3
Tue 12 14:45 Oral Communications 5 - Adrenal and Cardiovascular
Common variants in the gene encoding corticosteroid binding globulin influence cortisol-responsive gene networks in human adipose tissue
Claire Martin
Claire Martin
OC5.4
Tue 12 14:45 Oral Communications 5 - Adrenal and Cardiovascular
Pre-receptor metabolism and signalling of glucocorticoids between macrophages and fibroblasts
Xilin Wu
Xilin Wu
OC5.5
Tue 12 14:45 Oral Communications 5 - Adrenal and Cardiovascular
Somatic transmembrane domain mutations of a cell adhesion molecule, CADM1, cause primary aldosteronism by preventing gap junction communication between adrenocortical cells
Emily Goodchild
Emily Goodchild
OC5.6
Tue 12 14:45 Oral Communications 5 - Adrenal and Cardiovascular
SLC35F1, a potential marker for aldosterone producing cell clusters
Ali Abbara
Ali Abbara
OC6.1
Tue 12 14:45 Oral Communications 6 - Reproductive Endocrinology and Biology
Effect of MVT-602, a potent kisspeptin receptor agonist, on LH levels in healthy pre-menopausal women undergoing a minimal controlled ovarian stimulation protocol
Gillian Johnson
Gillian Johnson
OC6.2
Tue 12 14:45 Oral Communications 6 - Reproductive Endocrinology and Biology
Differential follicle stimulating hormone glycosylation modulates follicle growth and survival rates
Kate Timms
Kate Timms
OC6.3
Tue 12 14:45 Oral Communications 6 - Reproductive Endocrinology and Biology
Investigating the impact of altered maternal extracellular vesicle miRNAs on placental function in women with gestational diabetes complicated by large for gestational age infants
Soo Kim
Soo Kim
OC6.4
Tue 12 14:45 Oral Communications 6 - Reproductive Endocrinology and Biology
Kallmann syndrome-associated WDR11 regulates primordial germ cell development
Zhiyong Zou
Zhiyong Zou
OC6.5
Tue 12 14:45 Oral Communications 6 - Reproductive Endocrinology and Biology
Placental expression of estrogen related receptor γ (ERRγ) is hypoxia-sensitive and is altered in pregnancies complicated by fetal growth restriction
Lisa Yang
Lisa Yang
OC6.6
Tue 12 14:45 Oral Communications 6 - Reproductive Endocrinology and Biology
Kisspeptin Enhances the Brain Processing of Attraction in Men
Dr Phillip Yeoh
Phillip Yeoh
NS2.1
Tue 12 14:45 Nurses' session 2: Management of Hyper & Hypocalcaemia
Aetiology of hyper and hypocalcaemia
Professor Neil Gittoes
Neil Gittoes
NS2.2
Tue 12 14:45 Nurses' session 2: Management of Hyper & Hypocalcaemia
Patient management of hypercalcaemia & when should the surgeon intervene?
Professor Neil Gittoes
Neil Gittoes
ROE1.1
Wed 13 15:15 Endocrinology in the UK: Workforce, Standards, and Quality Improvement
National standards and the specialised endocrinology Clinical Reference Group
Professor Neil Gittoes
Neil Gittoes
CMW2.3
Wed 13 15:15 Clinical Management Workshop 2: Hyperparathyroidism
Challenges in recurrent hyperparathyroidism
Professor Jeremy Turner
Jeremy Turner
NS2.3
Tue 12 14:45 Nurses' session 2: Management of Hyper & Hypocalcaemia
Patient management of hypocalcaemia & the patient perspective
Professor Maralyn Druce
Maralyn Druce
ECS1.1
Tue 12 16:45 Early Careers Symposium: Engaging with the public
How your Society can help you engage the public
Chris Jones
Chris Jones
ECS1.2
Tue 12 16:45 Early Careers Symposium: Engaging with the public
Making the best of what you’re given – public engagement grants
Dr Giles Yeo
Giles Yeo
ECS1.5
Tue 12 16:45 Early Careers Symposium: Engaging with the public
Endocrinology in the public eye
Dr. Peter Taylor
Peter Taylor
HDI2.2
Tue 12 16:45 How do I…2
How should I manage non-standard thyroid hormone replacement
Liz Crowne
Liz Crowne
HDI2.3
Tue 12 16:45 How do I…2
When and how should I start screening for MEN1 in children
Dr Niki Karavitaki
Niki Karavitaki
HDI2.4
Tue 12 16:45 How do I…2
How do I decide when to initiate dopamine agonist withdrawal
Dr Claire Higham
Claire Higham
HDI2.5
Tue 12 16:45 How do I…2
How do I… manage therapeutic glucocorticoid withdrawal
Malcolm Peaker
Malcolm Peaker
SE1.1
Tue 12 16:45 Senior Endocrinologists' Session
What happened to the adrenal X-zone?
Richard Santen
Richard Santen
SE1.2
Tue 12 16:45 Senior Endocrinologists' Session
Is the estrogenic component of Premarin all bad?
Barbara Boucher
Barbara Boucher
SE1.3
Tue 12 16:45 Senior Endocrinologists' Session
Potential benefits of better vitamin D status for non-bony disorders?
Dr. Christine May
Christine May
SK1.1
Wed 13 09:35 Clincal Skills: Being a consultant - How to get the job and keep it
How to get the consultant post you want
Dr Nicola Zammitt
Nicola Zammitt
SK1.2
Wed 13 09:35 Clincal Skills: Being a consultant - How to get the job and keep it
How to approach your first job plan - Get it right first time/How to get the job you want
Andrew Lansdown
Andrew Lansdown
SK1.3
Wed 13 09:35 Clincal Skills: Being a consultant - How to get the job and keep it
How do I set up a new service?
Andrew Childs
Andrew Childs
SK2.1
Wed 13 09:35 Basic Skills: Introduction to teaching
Getting started in undergraduate teaching; what, when and how?
Professor Kevin Murphy
Kevin Murphy
SK2.2
Wed 13 09:35 Basic Skills: Introduction to teaching
Challenging students and difficult supervisors; how to supervise students effectively when things go wrong. 
Antonio Bianco
Antonio Bianco
S4.1
Wed 13 10:50 Symposium 4: Thyroid hormone a key regulator in inflammation?
Thyroid hormone inhibits lung fibrosis 
Francesca Spiga
Francesca Spiga
S5.2
Wed 13 10:50 Symposium 5: Stress – The rhythm of life
Dynamic of Adrenal in health and disease
Andrea Frilling
Andrea Frilling
S6.2
Wed 13 10:50 Symposium 6: New horizons in neuro-endocrine disease
Using genetics to inform on pharmalogical targeting of NETs
Jeremy Cobbold
Jeremy Cobbold
MTE4.1
Wed 13 12:25 Meet The Expert 4
Fighting liver fat
Professor Jeremy Tomlinson
Jeremy Tomlinson
MTE4.2
Wed 13 12:25 Meet The Expert 4
Fighting liver fat
Chas Bountra
Chas Bountra
MTE5
Wed 13 12:25 Meet The Expert 5
Novel Epigenetic inhibitors
Dr Jennifer Walsh
Jennifer Walsh
MTE6
Wed 13 12:25 Meet The Expert 6
What have we learned from HR-pQCT?
Robert Gifford
Robert Gifford
OP5.1
Wed 13 13:15 Oral Posters 5 - Reproductive Endocrinology and Biology
Hypothalamic-pituitary-gonadal (HPG) axis suppression during basic military training in women despite increased adiposity and insulin resistance
Douglas Gibson
Douglas Gibson
OP5.2
Wed 13 13:15 Oral Posters 5 - Reproductive Endocrinology and Biology
Profiling the expression and function of the truncated oestrogen receptor isoform ER46 in human endometrium
Maria Phylactou
Maria Phylactou
OP5.4
Wed 13 13:15 Oral Posters 5 - Reproductive Endocrinology and Biology
Kisspeptin as a novel biomarker for pregnancy complications
Waiel Bashari
Waiel Bashari
OC6.1
Wed 13 13:50 Oral Posters 6 - Neuroendocrinology, Pituitary and Neoplasia
Extended TSS (guided by 11C-methionine PET + MRI (Met-PET/MRCR)) can be an effective treatment option for patients with persistent acromegaly due to previously deemed unresectable lateral disease
Mark Bollington
Mark Bollington
OC6.2
Wed 13 13:50 Oral Posters 6 - Neuroendocrinology, Pituitary and Neoplasia
Transcriptomic analyses reveal deregulation of focal adhesion pathway in Aip KO mice and AIP mutation positive human tumours
Kate Lines
Kate Lines
OP6.3
Wed 13 13:50 Oral Posters 6 - Neuroendocrinology, Pituitary and Neoplasia
JQ1 treatment significantly reduces POMC expression and ACTH secretion from the corticotrophinoma cell line, AtT20
Vasileios Chortis
Vasileios Chortis
OP6.4
Wed 13 13:50 Oral Posters 6 - Neuroendocrinology, Pituitary and Neoplasia
Urine steroid metabolomics as a novel diagnostic tool for recurrent adrenocortical carcinoma detection
Stella George
Stella George
ROE1.4
Wed 13 15:15 Endocrinology in the UK: Workforce, Standards, and Quality Improvement
The 2018 diabetes and endocrinology consultant workforce survey (SfE/ABCD/DUK)
Rebecca Reynolds
Rebecca Reynolds
CMW2.1
Wed 13 15:15 Clinical Management Workshop 2: Hyperparathyroidism
Management of primary hyperparathyroidism in pregnancy
Soo-Mi Park
Soo-Mi Park
CMW2.2
Wed 13 15:15 Clinical Management Workshop 2: Hyperparathyroidism
Genetic testing in hyperparathyroidism across the ages- who to test and why
Aylin Hanyaloglu
Aylin Hanyaloglu
BPW2.2
Wed 13 15:15 Basic Physiology Workshop: Imaging endocrinology from networks to organelles
Spatial programming of GPCR signalling
Kathryn Garner
Kathryn Garner
BPW2.3
Wed 13 15:15 Basic Physiology Workshop: Imaging endocrinology from networks to organelles
High content imaging for monitoring signalling dynamics in single cells
Philippa Saunders
Philippa Saunders
PL9
Wed 13 16:50 Plenary 9: Society for Endocrinology Medal Lecture
Sex steroids and the endometrium: dynamics and disorders
Julian Davis
Julian Davis
PL10
Wed 13 17:30 Plenary 10: Society for Endocrinology Jubilee Medal Lecture
Pituitary cells alive: hormone genes pulsing on and off
Outi Mäkitie
Outi Mäkitie
IN1.1
Mon 11 17:05 Innovation Session 1: Advances in understanding skeletal disease
Identifying new skeletal disease
Martine Cohen-Solal
Martine Cohen-Solal
IN1.3
Mon 11 17:05 Innovation Session 1: Advances in understanding skeletal disease
Bone fragility in patients with chronic kidney diseases
Karine Rizzoti
Karine Rizzoti
IN2.1
Mon 11 17:05 Innovation Session 2: Big data in space and time
Single cell RNA-seq of endocrine organs
Dr Inês Cebola
Inês Cebola
EC1.1
Tue 12 09:35 Early Careers and Plenary Orals
Early Career Prize lecture Basic Science
Dr Tiganescu
Dr Tiganescu
EC1.2
Tue 12 09:35 Early Careers and Plenary Orals
Early Career Prize lecture Translational
Jenny Visser
Jenny Visser
S2.1
Tue 12 11:05 Symposium 2: New insights into PCOS
Fetal antecedents of PCOS is there a role of AMH?
Terhi Piltonen
Terhi Piltonen
S2.3
Tue 12 11:05 Symposium 2: New insights into PCOS
Origins of obesity in women with PCOS
Clemens Bergwitz
Clemens Bergwitz
S3.1
Tue 12 11:05 Symposium 3: Phosphate homeostasis physiology pathology and pharmacology
Advances in FGF23 Signalling
Laurent Beck
Laurent Beck
S3.2
Tue 12 11:05 Symposium 3: Phosphate homeostasis physiology pathology and pharmacology
Phosphate Sensing
Seiji Fukumoto
Seiji Fukumoto
S3.3
Tue 12 11:05 Symposium 3: Phosphate homeostasis physiology pathology and pharmacology
FGF23-Related Hypophosphatemic Diseases: Prospect for New Treatment
Aleksandra Buha
Aleksandra Buha
OC4.3
Tue 12 14:45 Oral Communications 4 - Thyroid
The disturbed thyroid gland homeostasis in conditions of subacute exposure to thyroid-disrupting chemicals: experimental study in Wistar rats
Julia Toews
Julia Toews
OC5.1
Tue 12 14:45 Oral Communications 5 - Adrenal and Cardiovascular
Central role for corticosteroid-binding globulin in rat HPA axis sexual dimorphism
Dr Helen Simpson
Helen Simpson
ECS1.3
Tue 12 16:45 Early Careers Symposium: Engaging with the public
How to reach out across social media
Ms. Anne Marland
Anne Marland
ECS1.4
Tue 12 16:45 Early Careers Symposium: Engaging with the public
Meaningful engagement with patients: The importance of recognising common humanity in patients is key to improving relationships’
Dr Rachel Crowley
Rachel Crowley
HDI2.6
Tue 12 16:45 How do I…2
How do I manage withdrawal of denosumab
Felix Beuschlein
Felix Beuschlein
PL6
Tue 12 18:20 Plenary 6: Society for Endocrinology European Medal Lecture
Mechanisms and consequences of endocrine autonomy – lessons learned from the adrenal cortex
James Fagin
James Fagin
PL7
Wed 13 08:30 Plenary 7: British Thyroid Association Pitt-Rivers Lecture
Thyroid cancer genomics, differentiation state and response to radioiodine
Jérôme Bertherat
Jérôme Bertherat
PL8
Wed 13 09:00 Plenary 8: CET Visiting Professor Lecture
Cushing’s syndrome as a model of endocrine tumorigenesis
Anne Spek
Anne Spek
S4.2
Wed 13 10:50 Symposium 4: Thyroid hormone a key regulator in inflammation?
Thyroid hormone regulation of Inflammation 
Henrik Oster
Henrik Oster
S5.1
Wed 13 10:50 Symposium 5: Stress – The rhythm of life
The interplay between stress, biological clocks and metabolic function
Simona Grozinsky-Glasberg
Simona Grozinsky-Glasberg
S6.1
Wed 13 10:50 Symposium 6: New horizons in neuro-endocrine disease
Preclinical drug studies for MEN1 NETs
Mark Gurnell
Mark Gurnell
MTE2
Tue 12 12:40 Meet The Expert 2
When should I consider functional imaging in adrenocortical disease?
Mark Gurnell
Mark Gurnell
S6.3
Wed 13 10:50 Symposium 6: New horizons in neuro-endocrine disease
Molecular endocrine imaging in occult de novo or recurrent pituitary disease
Bolanle Iranloye
Bolanle Iranloye
OP5.3
Wed 13 13:15 Oral Posters 5 - Reproductive Endocrinology and Biology
Stress is implicated in programming metabolic disorders in the offspring of fructose-induced diabetic rats
Professor John Wass
John Wass
ROE1.2
Wed 13 15:15 Endocrinology in the UK: Workforce, Standards, and Quality Improvement
GIRFT Getting it Right First Time in endocrinology
Patrice Mollard
Patrice Mollard
BPW2.1
Wed 13 15:15 Basic Physiology Workshop: Imaging endocrinology from networks to organelles
In vivo imaging of endocrine cell networks
Dr. Kate Lines
Kate Lines
OC3.4
Mon 11 15:05 Oral Communications 3 - Bone and Calcium
Characterisation of rare GNA11 variants reveals 8 novel residues important for signalling by the calcium-sensing receptor: Relevance for FHH and ADH
Dr. Kate Lines
Kate Lines
OP3.4
Tue 12 13:30 Oral Posters 3 - Metabolism and Obesity
Mice with a gain-of function Gα11 mutation have autosomal dominant hypocalcaemia, but not impaired glucose metabolism.
Mon 11
10:20 - 10:50 
What Is New
Auditorium 2
Chair: Duncan Bassett (Imperial College London, United Kingdom)
WIN1
10:20
WIN1
What is New in Basic Endocrinology Research
Caroline Gorvin (Birmingham, United Kingdom )
10:35
WIN2
What is New in Clinical Endocrinology Research
John Newell-Price (Sheffield, UK)
Mon 11
11:05 - 12:35 
Clinical Management Workshop 1: Salt & Water
Don’t be hung out ‘too’ dry
Endocrinology, Diabetes and Metabolism Case Reports
Syndicate 1 & 2
Chairs: Helen Simpson (University College London Hospital, United Kingdom) & Hussam Rostom (Oxford University Hospitals, United Kingdom)
Clinical Management Workshop
11:05
CMW1.1
Management of hyponatraemia
Steve Ball (Manchester, United Kingdom)
11:35
CMW1.2
Diabetes Insipidus - management challenges and pitfalls
Mark Hannon (Bantry, Ireland)
12:05
CMW1.3
Co-peptin- a new player in the diagnosis of salt and water balance
Mirjam Christ-Crain (Basel, Switzerland)
Mon 11
11:05 - 12:35 
Basic Physiology Workshop: Modelling endocrinology in vitro, in vivo & in silico
Journal of Endocrinology
Syndicate 3 & 4
Chairs: Francesca Spiga (University of Bristol, United Kingdom) & Bryn Owen (Imperial College London, United Kingdom)
Basic Physiology Workshop
11:05
BPW1.1
In vivo models of endocrinology: new zebrafish models
Francesco Argenton (Padua, Italy)
11:35
BPW1.2
In vitro models of endocrinology: organoids from pituitary and endometrium
Hugo Vankelecom (Leuven, Belgium)
12:05
BPW1.3
In silico models of endocrinology: mathematical modelling of endocrine systems
Margaritis Voliotis (Exeter, United Kingdom)
Wed 13
15:15 - 16:45 
Clinical Management Workshop 2: Hyperparathyroidism
Auditorium 2
Chairs: Jeremy Turner (Norfolk and Norwich University Hospital, United Kingdom) & Anna Crown (Royal Sussex County Hospital, Brighton, United Kingdom)
15:15
CMW2.1
Management of primary hyperparathyroidism in pregnancy
Rebecca Reynolds (Edinburgh, United Kingdom)
15:45
CMW2.2
Genetic testing in hyperparathyroidism across the ages- who to test and why
Soo-Mi Park (Cambridge, United Kingdom)
16:15
CMW2.3
Challenges in recurrent hyperparathyroidism
Neil Gittoes (Birmingham, United Kingdom)
Wed 13
15:15 - 16:45 
Basic Physiology Workshop: Imaging endocrinology from networks to organelles
Journal of Molecular Endocrinology
Syndicate 1 & 2
Chairs: Davide Calebiro (University of Birmingham, United Kingdom) & David Hodson (University of Birmingham, United Kingdom)
15:15
BPW2.1
In vivo imaging of endocrine cell networks
Patrice Mollard (Montpellier, France)
15:45
BPW2.2
Spatial programming of GPCR signalling
Aylin Hanyaloglu (London, United Kingdom)
16:15
BPW2.3
High content imaging for monitoring signalling dynamics in single cells
Kathryn Garner (Newcastle-Upon-Tyne, United Kingdom)
Mon 11
12:45 - 13:15 
Oral Posters 1 - Adrenal and Cardiovascular
SfE Theatre
Chairs: Michael O'Reilly (Royal College of Surgeons in Ireland, Dublin, Ireland) & Scott MacKenzie (University of Glasgow, United Kingdom)
12:50
OP1.1
Betamethasone/GR ChIP-Seq analysis defines a discrete set of canonical GR homodimer binding sites in primary fetal rat lung mesenchymal fibroblasts
Timothy Cole (Melbourne, Australia)
12:55
OP1.2
ABSTRACT WITHDRAWN
13:00
OP1.3
Combining 11C-Metomidate PET/CT and 18F-FDG PET/CT – a new approach to phenotyping indeterminate adrenal lesions
Russell Senanayake (Cambridge, United Kingdom)
13:05
OP1.4
Global phosphoproteomics links rapidly induced cytoplasmic signals to transcriptional control
Fiona Leslie (Leeds, United Kingdom)
Mon 11
13:20 - 13:50 
Oral Posters 2 - Thyroid
SfE Theatre
Chairs: Carla Moran (Beacon Hospital, Dublin, Ireland) & Jacqueline Gilbert (King's College Hospital, London, United Kingdom)
13:25
OP2.1
Day case radioiodine for remnant ablation in differentiated thyroid cancer patients is safe and helps reduce bed pressures in a busy tertiary centre hospital
Shazia Hussain (London, United Kingdom)
13:30
OP2.2
The SH2B3 tryptophan 262 variant is associated with Graves’ disease and Addison’s disease
Georgina Sneddon (Newcastle upon Tyne, United Kingdom)
13:35
OP2.3
Sustained improvements in monitoring and biochemical control of hypothyroidism in primary care with the use of an electronic protocol at two year follow up
Anh Tran (Worcester Park, United Kingdom)
13:40
OP2.4
The proto-oncogene PBF mediates Src modulation of radioiodine uptake
Mohammed Alshahrani (Birmingham, United Kingdom)
Mon 11
15:05 - 16:35 
Oral Communications 1 - Metabolism and Obesity
Auditorium 2
Chairs: Abd Taharni (University of Birmingham, United Kingdom) & Zoi Michailidou (Edinburgh University, United Kingdom)
15:05
OC1.1
Intracrine activation of 11-oxygenated androgens by AKR1C3 modulates lipid metabolism in human female adipose tissue
Lina Schiffer (Birmingham, United Kingdom)
15:20
OC1.2
Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism
Leanne Hodson (Oxford, United Kingdom)
15:35
OC1.3
Metabolic and functional effects of fatty acid overload on in vitro tissue engineered skeletal muscle.
Mark Turner (Coventry , United Kingdom)
15:50
OC1.4
5β-reductase (AKR1D1) is downregulated in patients with non-alcoholic fatty liver disease and protects against hepatocellular carcinoma cell proliferation in vitro.
Nikolaos Nikolaou (Oxford, United Kingdom)
16:05
OC1.5
Prolyl-hydroxylase 3 maintains β-cell glucose-sensing under metabolic stress
Federica Cuozzo (Birmingham, United Kingdom)
16:20
OC1.6
Metabolic surgery reduces kidney SGLT2 expression in mice
Elina Akalestou (London, United Kingdom)
Mon 11
15:05 - 16:35 
Oral Communications 2 - Neuroendocrinology, Pituitary and Neoplasia
Syndicate 1 & 2
Chairs: Ashley Grossman (University of Oxford, United Kingdom) & Simona Grozinsky-Glasberg (Hadassah-Hebrew University Hospital, Israel)
15:05
OC2.1
Differential effects of subcutaneous pulsatile versus oral hydrocortisone replacement therapy on fMRI resting state and task based emotional processing in Patients with Primary Adrenal insufficiency
Georgina Russell (Bristol, United Kingdom)
15:20
OC2.2
Investigating the role of AIP in pituitary tumourigenesis
Anisha Mistry (London, United Kingdom)
15:35
OC2.3
ErbB receptor signalling in MCF7 breast cancer cells: an information theoretic approach
Robert Pope (Bristol Medical School, United Kingdom)
15:50
OC2.4
Investigating the role of vagal Y2R in PYY3-36-mediated appetite suppression
Aldara Alonso (London, United Kingdom)
16:05
OC2.5
Efnb2 controls pituitary gland development by regulating proliferation of the pituitary stem/progenitor cells and EMT within the pituitary stem cell niche.
Angelica Gualtieri (London, United Kingdom)
16:20
OC2.6
Post-operative copeptin analysis as a predictor of diabetes insipidus after pituitary surgery
Hussam Rostom (Oxford, United Kingdom)
Mon 11
15:05 - 16:35 
Oral Communications 3 - Bone and Calcium
Syndicate 3 & 4
Chairs: Fadil Hannan (University of Oxford, United Kingdom) & Jennie Walsh (University of Sheffield, United Kingdom)
15:05
OC3.1
A mouse model generated by CRISPR-Cas9 with a frameshift mutation in the nuclear factor 1/X (NFIX) gene has phenotypic features reported in Marshall-Smith Syndrome (MSS) patients
Kreepa Kooblall (Oxford, United Kingdom)
15:20
OC3.2
Hypophosphatasia in adulthood - are patients really “unaffected”
Zhuo Chong (Glasgow, United Kingdom)
15:35
OC3.3
Generation of a long acting parathyroid hormone hybrid analogue through fusion to a binding protein
Lina Sorour (Sheffield, United Kingdom)
15:50
OC3.4
Characterisation of rare GNA11 variants reveals 8 novel residues important for signalling by the calcium-sensing receptor: Relevance for FHH and ADH
Kate Lines (Oxford, UK)
16:05
OC3.5
Mutational analysis of a patient with familial hypocalciuric hypercalcaemia identifies a novel p.Ser182Cys mutation, which is predicted to disrupt the calcium sensing receptor (CaSR) extracellular domain
Ultan Healy (Oxford, United Kingdom)
16:20
OC3.6
The role of biased calcium-sensing receptor signalling in urinary calcium excretion and kidney stone disease
Michelle Goldsworthy (Oxford, United Kingdom)
Tue 12
09:35 - 10:35 
Early Careers and Plenary Orals
Auditorium 2
Chairs: Stephanie Baldeweg (University College London University, United Kingdom) & Chris McCabe (University of Birmingham, United Kingdom)
09:35
EC1.1
Early Career Prize lecture Basic Science
Inês Cebola (London, United Kingdom)
09:55
EC1.2
Early Career Prize lecture Translational
Dr Tiganescu (Leeds, United Kingdom))
10:15
EC1.3
Urine steroid metabolome analysis allows for metabolic risk stratification in 1309 prospectively recruited patients with benign adrenal tumours and different degrees of cortisol excess
Alessandro Prete (Birmingham, United Kingdom)
10:25
EC1.4
CET Best Abstract Basic
Fadil Hannan (Oxford, United Kingdom)
Tue 12
13:30 - 14:00 
Oral Posters 3 - Metabolism and Obesity
SfE Theatre
Chairs: Barbara McGowan (Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom) & Kevin Murphy (Imperial College, London, United Kingdom)
13:35
OP3.1
Intermittent cold exposure ameliorates fatty liver disease
Alice Mitchell (London, United Kingdom)
13:40
OP3.2
Intestinal injury and evidence of increased gut permeability in female AKR1D1 knockout mice
Anastasia Arvaniti (Oxford, United Kingdom)
13:45
OP3.3
The Impact of Subcutaneous Infusions of three Anorexigenic Gut Hormones Glucagon-like Peptide-1, Oxyntomodulin and Peptide YY (GOP) on the Psychological Health of Obese Diabetic Patients.
Haya Alessimii (London, United Kingdom)
13:50
OP3.4
Mice with a gain-of function Gα11 mutation have autosomal dominant hypocalcaemia, but not impaired glucose metabolism.
Kate Lines (Oxford, UK)
Tue 12
14:05 - 14:35 
Oral Posters 4 - Bone and Calcium
SfE Theatre
Chairs: Jeremy Turner (Norfolk and Norwich University Hospital, United Kingdom) & Caroline Gorvin (University of Birmingham, United Kingdom)
14:10
OP4.1
Oral calcium loading test can predict the progression of hypercalcaemic primary hyperparathyroidism in patients with normocalcaemic hyperparathyroidism
Kanapath Oungpasuk (London, United Kingdom)
14:15
OP4.2
Identification of novel pathogenic variants and phenotypic features in patients with pseudohypoparathyroidism and acrodysostosis, subtypes of the newly defined inactivating PTH/PTHrP signalling disorders (iPPSD) classification system
Adam Truelove (Cambridge, United Kingdom)
14:20
OP4.3
Mendelian randomization and machine learning to assess the causal association of Type 2 Diabetes with osteoporosis and fragility fractures
Harshal Deshmukh (Hull, United Kingdom)
14:25
OP4.4
The associations between body fat distribution and bone mineral density in the Oxford Biobank: a cross sectional study
Catriona Hilton (Oxford, United Kingdom)
Tue 12
14:45 - 16:15 
Oral Communications 4 - Thyroid
Syndicate 1 & 2
Chairs: Krish Chatterjee (University of Cambridge, United Kingdom) & Anna Mitchell (Newcastle University, United Kingdom)
14:45
OC4.1
A high-throughput yellow fluorescent protein (YFP) cell-based screen identifies autophagy modulators to increase the effectiveness of radioiodine therapy
Martin Read (Birmingham, United Kingdom)
15:00
OC4.2
Reduced Length of Hospital Stay with the use of recombinant TSH compared to Thyroid Hormone Withdrawal –A two centre retrospective study
Mohammad Jeeyavudeen (Aberdeen, United Kingdom)
15:15
OC4.3
The disturbed thyroid gland homeostasis in conditions of subacute exposure to thyroid-disrupting chemicals: experimental study in Wistar rats
Aleksandra Buha (Belgrade, Serbia)
15:30
OC4.4
Development of auto-immune thyroid dysfunction in multiple sclerosis patients receiving Alemtuzumab is associated with improved response to treatment
Alina Sovetkina (London, United Kingdom)
15:45
OC4.5
The prevalence of thyroid dysfunction and autoimmunity in women with history of miscarriage or subfertility across the United Kingdom
Rima Dhillon-Smith (Birmingham, United Kingdom)
16:00
OC4.6
Driver events in thyroid cancer recurrence
Hannah Nieto (Birmingham, United Kingdom)
Tue 12
14:45 - 16:15 
Oral Communications 5 - Adrenal and Cardiovascular
Auditorium 2
Chairs: Mark Nixon (University of Edinburgh, United Kingdom) & Francesca Spiga (University of Bristol, United Kingdom)
14:45
OC5.1
Central role for corticosteroid-binding globulin in rat HPA axis sexual dimorphism
Julia Toews (Vancouver, Canada)
15:00
OC5.2
Subclinical alpha-1 antitrypsin deficiency is associated with increased free cortisol fraction in plasma
Luke Boyle (Edinburgh, United Kingdom)
15:15
OC5.3
Common variants in the gene encoding corticosteroid binding globulin influence cortisol-responsive gene networks in human adipose tissue
Sean Bankier (Edinburgh, United Kingdom)
15:30
OC5.4
Pre-receptor metabolism and signalling of glucocorticoids between macrophages and fibroblasts
Claire Martin (Birmingham, United Kingdom)
15:45
OC5.5
Somatic transmembrane domain mutations of a cell adhesion molecule, CADM1, cause primary aldosteronism by preventing gap junction communication between adrenocortical cells
Xilin Wu (London, United Kingdom)
16:00
OC5.6
SLC35F1, a potential marker for aldosterone producing cell clusters
Emily Goodchild (London, United Kingdom)
Tue 12
14:45 - 16:15 
Oral Communications 6 - Reproductive Endocrinology and Biology
Syndicate 3 & 4
Chairs: Andy Childs (Imperial College London, United Kingdom) & Phillipa Saunders (The University of Edinburgh, United Kingdom)
14:45
OC6.1
Effect of MVT-602, a potent kisspeptin receptor agonist, on LH levels in healthy pre-menopausal women undergoing a minimal controlled ovarian stimulation protocol
Ali Abbara (London, United Kingdom)
15:00
OC6.2
Differential follicle stimulating hormone glycosylation modulates follicle growth and survival rates
Gillian Johnson (London, United Kingdom)
15:15
OC6.3
Investigating the impact of altered maternal extracellular vesicle miRNAs on placental function in women with gestational diabetes complicated by large for gestational age infants
Kate Timms (Leeds, United Kingdom)
15:30
OC6.4
Kallmann syndrome-associated WDR11 regulates primordial germ cell development
Soo Kim (London, United Kingdom)
15:45
OC6.5
Placental expression of estrogen related receptor γ (ERRγ) is hypoxia-sensitive and is altered in pregnancies complicated by fetal growth restriction
Zhiyong Zou (Manchester, United Kingdom)
16:00
OC6.6
Kisspeptin Enhances the Brain Processing of Attraction in Men
Lisa Yang (London, United Kingdom)
Wed 13
13:15 - 13:45 
Oral Posters 5 - Reproductive Endocrinology and Biology
SfE Theatre
Chairs: Colin Duncan (University of Edinburgh, United Kingdom) & Andrew Childs (Imperial College London, United Kingdom)
13:20
OP5.1
Hypothalamic-pituitary-gonadal (HPG) axis suppression during basic military training in women despite increased adiposity and insulin resistance
Robert Gifford (Edinburgh, United Kingdom)
13:25
OP5.2
Profiling the expression and function of the truncated oestrogen receptor isoform ER46 in human endometrium
Douglas Gibson (Edinburgh, United Kingdom)
13:30
OP5.3
Stress is implicated in programming metabolic disorders in the offspring of fructose-induced diabetic rats
Bolanle Iranloye (Lagos, Nigeria)
13:35
OP5.4
Kisspeptin as a novel biomarker for pregnancy complications
Maria Phylactou (London, United Kingdom)
Wed 13
13:50 - 14:20 
Oral Posters 6 - Neuroendocrinology, Pituitary and Neoplasia
SfE Theatre
Chairs: Craig Beall (University of Exeter, United Kingdom) & Paul Newey (University of Dundee, United Kingdom)
13:55
OC6.1
Extended TSS (guided by 11C-methionine PET + MRI (Met-PET/MRCR)) can be an effective treatment option for patients with persistent acromegaly due to previously deemed unresectable lateral disease
Waiel Bashari (Cambridge, United Kingdom)
14:00
OC6.2
Transcriptomic analyses reveal deregulation of focal adhesion pathway in Aip KO mice and AIP mutation positive human tumours
Mark Bollington (London, United Kingdom)
14:05
OP6.3
JQ1 treatment significantly reduces POMC expression and ACTH secretion from the corticotrophinoma cell line, AtT20
Kate Lines (Oxford, United Kingdom)
14:10
OP6.4
Urine steroid metabolomics as a novel diagnostic tool for recurrent adrenocortical carcinoma detection
Vasileios Chortis (Birmingham, United Kingdom)
Tue 12
12:40 - 13:25 
Meet The Expert 1
Endocrine Connections
Syndicate 1 & 2
12:40
MTE1
Thyroid disease after immune reconstitution
Carla Moran (Dublin, Ireland)
Tue 12
12:40 - 13:25 
Meet The Expert 2
Auditorium 2
12:40
MTE2
When should I consider functional imaging in adrenocortical disease?
Mark Gurnell (Cambridge, United Kingdom)
Tue 12
12:40 - 13:25 
Meet The Expert 3
Syndicate 3 & 4
12:40
MTE3
Update on DSD genetics
John Achermann (London, United Kingdom)
Wed 13
12:25 - 13:10 
Meet The Expert 4
Endocrine Connections
Auditorium 2
12:25
MTE4.1
Fighting liver fat
Jeremy Cobbold ( Oxford, United Kingdom)
12:47
MTE4.2
Fighting liver fat
Jeremy Tomlinson (Oxford, United Kingdom)
Wed 13
12:25 - 13:10 
Meet The Expert 5
Endocrine Related Cancer
Syndicate 1 & 2
12:25
MTE5
Novel Epigenetic inhibitors
Chas Bountra (Oxford, United Kingdom)
Wed 13
12:25 - 13:10 
Meet The Expert 6
Syndicate 3 & 4
12:25
MTE6
What have we learned from HR-pQCT?
Jennifer Walsh (Sheffield, United Kingdom)
Mon 11
14:00 - 14:30 
Plenary 1:Clinical Endocrinology Trust Lecture
Auditorium 2
Chair: John Newell-Price (University of Sheffield, United Kingdom)
14:00
PL1
Controlling cortisol in cardiometabolic disease
Brian Walker (Edinburgh, UK)
Mon 11
14:30 - 15:00 
Plenary 2: Society for Endocrinology Starling Medal Lecture
Auditorium 2
Chair: Graham Williams (Imperial College London, United Kingdom)
14:30
PL2
From its origins to the modern metabolic network
Markus Ralser (London, United Kingdom)
Mon 11
18:10 - 18:40 
Plenary 3: Society for Endocrinology Dale Medal Lecture
Auditorium 2
Chair: Duncan Bassett (Imperial College London, United Kingdom)
18:10
PL3
From Carney complex to gigantism and Cushing disease: an insight in the genetics of pituitary tumors
Constantine Stratakis (Rockville, USA)
Tue 12
08:30 - 09:00 
Plenary 4: Society for Endocrinology Transatlantic Medal Lecture
Auditorium 2
Chair: Raj Thakker (University of Oxford, United Kingdom)
08:30
PL4
How is alkaline phosphatase essential for bone? The Transatlantic stories
Michael Whyte (St Louis, USA)
Tue 12
18:20 - 18:50 
Plenary 6: Society for Endocrinology European Medal Lecture
Auditorium 2
Chair: Eleanor Davies (University of Glasgow, United Kingdom)
18:20
PL6
Mechanisms and consequences of endocrine autonomy – lessons learned from the adrenal cortex
Felix Beuschlein (Zürich, Switzerland)
Wed 13
08:30 - 09:00 
Plenary 7: British Thyroid Association Pitt-Rivers Lecture
Auditorium 2
Chair: Krish Chatterjee (University of Cambridge, United Kingdom)
08:30
PL7
Thyroid cancer genomics, differentiation state and response to radioiodine
James Fagin (New York, USA))
Wed 13
09:00 - 09:30 
Plenary 8: CET Visiting Professor Lecture
Auditorium 2
Chair: Steve Ball (Manchester University Foundation Trust, United Kingdom)
09:00
PL8
Cushing’s syndrome as a model of endocrine tumorigenesis
Jérôme Bertherat (Paris, France)
Wed 13
16:50 - 17:20 
Plenary 9: Society for Endocrinology Medal Lecture
Auditorium 2
Chair: Raj Thakker (University of Oxford, United Kingdom)
16:50
PL9
Sex steroids and the endometrium: dynamics and disorders
Philippa Saunders (Edinburgh, United Kingdom)
Wed 13
17:30 - 18:00 
Plenary 10: Society for Endocrinology Jubilee Medal Lecture
Auditorium 2
Chair: Graham Williams (Imperial College London, United Kingdom)
17:30
PL10
Pituitary cells alive: hormone genes pulsing on and off
Julian Davis (Manchester, United Kingdom)
Mon 11
12:35 - 13:55 
LUNCH, EXHIBITION, SATELLITES & POSTERS
Auditorium 1
Mon 11
16:35 - 17:05 
TEA & COFFEE
Auditorium 1
Mon 11
19:25 - 20:30 
Presidential Welcome Reception
Tue 12
10:35 - 11:05 
TEA & COFFEE
Auditorium 1
Tue 12
13:25 - 14:40 
LUNCH, EXHIBITION & POSTERS
Auditorium 1
Tue 12
16:15 - 16:45 
TEA & COFFEE
Auditorium 1
Wed 13
10:20 - 10:50 
TEA & COFFEE
Auditorium 1
Wed 13
13:10 - 14:25 
LUNCH, EXHIBITION & POSTERS
Auditorium 1
Tue 12
11:05 - 12:35 
Nurses' session 1: NICE & T3
Meeting Room 9
Chairs: Louise Breen (Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom) & Emily Falconer (Maidstone and Tunbridge Wells Trust, United Kingdom)
11:05
NS1.1
T3 replacement – What does the evidence suggest?
Bijay Vaidya (Exeter, United Kingdom)
11:35
NS1.2
The health care professional & patient consultation - Informed decision making
Antonia Brooke (Exeter, UK)
12:05
NS1.3
A Beginners Guide: setting up a Nurse-Led Thyroid Clinic
Jean Munday (Portsmouth, United Kingdom)
Tue 12
14:45 - 16:15 
Nurses' session 2: Management of Hyper & Hypocalcaemia
Overflow room (to the left of the Registration desks)
Chairs: Sherwin Criseno (University Hospital Birmingham, United Kingdom) & Lisa Shepherd (University Hospital Birmingham, United Kingdom)
14:45
NS2.1
Aetiology of hyper and hypocalcaemia
Phillip Yeoh (London, United Kingdom)
15:15
NS2.2
Patient management of hypercalcaemia & when should the surgeon intervene?
Neil Gittoes (Birmingham, United Kingdom)
15:45
NS2.3
Patient management of hypocalcaemia & the patient perspective
Jeremy Turner (Norwich, United Kingdom)
Mon 11
09:00 - 21:00 
REGISTRATION
Mon 11
11:05 - 12:35 
How do I…1
Endocrine Connections
Auditorium 2
Chairs: Annice Mukherjee (Spire Manchester Hospital, United Kingdom) & Channa Jayasena (Imperial College London, United Kingdom)
11:05
HDI1.1
Management of osteoporosis in children and adolescents
Sophia Sakka (London, United Kingdom)
11:20
HDI1.2
How do I manage an incidental finding of a thyroid nodule
Kristien Boelaert (Birmingham , United Kingdom)
11:35
HDI1.3
How do I decide which patients with gynaecomastia need more detailed evaluation?
Sarah Ali (London, United Kingdom)
11:50
HDI1.4
How do I manage hair loss and hair growth in PCOS?
Aled Rees (Cardiff, United Kingdom)
12:05
HDI1.5
How do I induce spermatogenesis?
Umasuthan Srirangalingam (London, United Kingdom)
12:20
HDI1.6
How do I choose between weight loss interventions?
Abd Tahrani (Birmingham, United Kingdom )
Mon 11
17:05 - 18:05 
Innovation Session 1: Advances in understanding skeletal disease
Endocrine Connections
Syndicate 3 & 4
Chairs: Graham Williams (Imperial College London, United Kingdom) & Clemens Bergwitz (Yale School of Medicine, New Haven, USA)
17:05
IN1.1
Identifying new skeletal disease
Outi Mäkitie (Helsinki, Finland)
17:25
IN1.2
Hyponatremia and osteoporosis
Joseph Verbalis (Georgetown University, USA)
17:45
IN1.3
Bone fragility in patients with chronic kidney diseases
Martine Cohen-Solal (Paris, France)
Mon 11
17:05 - 18:05 
Innovation Session 2: Big data in space and time
Journal of Molecular Endocrinology
Syndicate 1 & 2
Chairs: Kathryn McGinnis (University of Leeds, United Kingdom) & Davide Calebiro (University of Birmingham, United Kingdom)
17:05
IN2.1
Single cell RNA-seq of endocrine organs
Karine Rizzoti (London, United Kingdom)
17:35
IN2.2
Data Science Approaches to GPCRs and Nuclear Receptors
M. Babu ((Cambridge, United Kingdom))
Mon 11
18:40 - 19:25 
Debate: Nature vs Nurture
Auditorium 2
Chair: Rob Semple (University of Edinburgh, United Kingdom)
18:40
D1.1
AGAINST - This house believes nature not nurture determines our bodyweight
John Wilding (Liverpool, United Kingdom)
18:40
D1.2
FOR - This house believes nature not nurture determines our bodyweight
Sadaf Farooqi (Cambridge, UK)
Tue 12
07:30 - 19:00 
REGISTRATION
Tue 12
16:45 - 18:15 
How do I…2
Auditorium 2
Chairs: Catherine Napier (Newcastle upon Tyne Hospitals, United Kingdom) & Kristien Boelaert (University of Birmingham, United Kingdom)
16:45
HDI2.1
How do I diagnose cyclical Cushing's
John Newell-Price (Sheffield, UK)
17:00
HDI2.2
How should I manage non-standard thyroid hormone replacement
Peter Taylor (Cardiff, United Kingdom)
17:15
HDI2.3
When and how should I start screening for MEN1 in children
Liz Crowne (Bristol, United Kingdom)
17:30
HDI2.4
How do I decide when to initiate dopamine agonist withdrawal
Niki Karavitaki (Birmingham, United Kingdom)
17:45
HDI2.5
How do I… manage therapeutic glucocorticoid withdrawal
Claire Higham (Manchester, United Kingdom)
18:00
HDI2.6